Lilly’s $400 Billion Surge Reshapes Big Pharma, Rally
Eli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
Yearly performance of total market index funds provides a broad view of winners and laggards. Use these insights to adjust your exposure today.
28,320 articlesEli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
In a land of hype cycles and volatile headlines, a strong cash-flow machine can outlast the fiercest cannabis hype. T...
Market fear is loud, but smart investors look for resilient opportunities. Here’s why I’m adding a tech stock to my p...
As Berkshire Hathaway prepares for a new era, Warren Buffett successor Greg Abel may be quietly orchestrating a bold,...
A broad coalition urges the Senate to take up the CLARITY Act, intensifying the fight over crypto regulation even as ...
Dream Finders has offered cash to acquire Beazer at roughly $32 per share, elevating the stakes for both companies. T...
Urban air mobility could redefine city travel, and Archer Aviation sits at the center of that promise. This guide bre...
Planet Labs delivered its first full year of profitability, with a ballooning backlog and AI partnerships driving a r...
Dell stocks jumped ahead this week as rival Lenovo signals hint at broader hardware demand. This guide breaks down wh...
SpaceX shares declined about 7% after the Federal Reserve kept rates steady, ending a brief three-day rally since its...
As earnings season hits, the focus is on Taiwan Semiconductor. This original analysis breaks down why prediction: Tai...
Lucid Group shares fell about 6% as investors grilled the company after a mixed Investor Day, with widening losses an...